GREGORY D BOROWSKI

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SCRANTON, PA NPI 1104800341

General Payments — all program years on this page

$58,025.00

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 113
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $359.02 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $359.029

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $223.726
Tandem Diabetes Care, Inc. $105.501
Novo Nordisk AS $15.421
Lilly USA, LLC $14.381

By program year

Program yearAmountRecords
2018 $21,309.4251
2019 $29,577.3836
2020 $4,955.706
2021 $1,646.884
2022 $45.383
2023 $131.224
2024 $359.029

Records — PY2024 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096596284 Novo Nordisk Inc $15.42 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874143 Boehringer Ingelheim Pharmaceuticals, Inc. $18.49 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874145 Boehringer Ingelheim Pharmaceuticals, Inc. $19.12 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874147 Boehringer Ingelheim Pharmaceuticals, Inc. $20.41 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874149 Boehringer Ingelheim Pharmaceuticals, Inc. $20.62 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874151 Boehringer Ingelheim Pharmaceuticals, Inc. $25.38 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874153 Boehringer Ingelheim Pharmaceuticals, Inc. $119.70 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134990216 Lilly USA, LLC $14.38 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138750543 Tandem Diabetes Care, Inc. $105.50 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.